These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 39034725)
41. Patenting of nanopharmaceuticals in drug delivery: no small issue. du Toit LC; Pillay V; Choonara YE; Pillay S; Harilall SL Recent Pat Drug Deliv Formul; 2007; 1(2):131-42. PubMed ID: 19075880 [TBL] [Abstract][Full Text] [Related]
42. Recent Advances in Self-Assembled Nanoparticles for Drug Delivery. Varma LT; Singh N; Gorain B; Choudhury H; Tambuwala MM; Kesharwani P; Shukla R Curr Drug Deliv; 2020; 17(4):279-291. PubMed ID: 32039683 [TBL] [Abstract][Full Text] [Related]
43. Nano spray drying for encapsulation of pharmaceuticals. Arpagaus C; Collenberg A; Rütti D; Assadpour E; Jafari SM Int J Pharm; 2018 Jul; 546(1-2):194-214. PubMed ID: 29778825 [TBL] [Abstract][Full Text] [Related]
44. Surface engineering of iron oxide nanoparticles for targeted cancer therapy. Kievit FM; Zhang M Acc Chem Res; 2011 Oct; 44(10):853-62. PubMed ID: 21528865 [TBL] [Abstract][Full Text] [Related]
45. Nanoparticle hardness controls the internalization pathway for drug delivery. Li Y; Zhang X; Cao D Nanoscale; 2015 Feb; 7(6):2758-69. PubMed ID: 25585060 [TBL] [Abstract][Full Text] [Related]
46. Insights into cellular uptake of nanoparticles. Kafshgari MH; Harding FJ; Voelcker NH Curr Drug Deliv; 2015; 12(1):63-77. PubMed ID: 25146441 [TBL] [Abstract][Full Text] [Related]
47. A bird's eye view of nanoparticles prepared by electrospraying: advancements in drug delivery field. Pawar A; Thakkar S; Misra M J Control Release; 2018 Sep; 286():179-200. PubMed ID: 30053427 [TBL] [Abstract][Full Text] [Related]
48. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. Liu Y; Miyoshi H; Nakamura M Int J Cancer; 2007 Jun; 120(12):2527-37. PubMed ID: 17390371 [TBL] [Abstract][Full Text] [Related]
49. The importance of nanoparticle shape in cancer drug delivery. Truong NP; Whittaker MR; Mak CW; Davis TP Expert Opin Drug Deliv; 2015 Jan; 12(1):129-42. PubMed ID: 25138827 [TBL] [Abstract][Full Text] [Related]
50. Mesoporous silica nanoparticles in target drug delivery system: A review. Bharti C; Nagaich U; Pal AK; Gulati N Int J Pharm Investig; 2015; 5(3):124-33. PubMed ID: 26258053 [TBL] [Abstract][Full Text] [Related]
51. Historical Perspective of Clinical Nano and Microparticle Formulations for Delivery of Therapeutics. Batty CJ; Bachelder EM; Ainslie KM Trends Mol Med; 2021 Jun; 27(6):516-519. PubMed ID: 33903019 [TBL] [Abstract][Full Text] [Related]
52. Soft- and hard-lipid nanoparticles: a novel approach to lymphatic drug delivery. Jeong SH; Jang JH; Cho HY; Lee YB Arch Pharm Res; 2018 Aug; 41(8):797-814. PubMed ID: 30074202 [TBL] [Abstract][Full Text] [Related]
53. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery. Ma X; Zhao Y; Ng KW; Zhao Y Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533 [TBL] [Abstract][Full Text] [Related]
54. Mesoporous silica nanoparticles: synthesis methods and their therapeutic use-recent advances. Ghaferi M; Koohi Moftakhari Esfahani M; Raza A; Al Harthi S; Ebrahimi Shahmabadi H; Alavi SE J Drug Target; 2021 Feb; 29(2):131-154. PubMed ID: 32815741 [TBL] [Abstract][Full Text] [Related]
55. Shape matters when engineering mesoporous silica-based nanomedicines. Hao N; Li L; Tang F Biomater Sci; 2016 Apr; 4(4):575-91. PubMed ID: 26818852 [TBL] [Abstract][Full Text] [Related]
56. Role of Nanoparticle Mechanical Properties in Cancer Drug Delivery. Hui Y; Yi X; Hou F; Wibowo D; Zhang F; Zhao D; Gao H; Zhao CX ACS Nano; 2019 Jul; 13(7):7410-7424. PubMed ID: 31287659 [TBL] [Abstract][Full Text] [Related]
57. Progress in developing amphiphilic cyclodextrin-based nanodevices for drug delivery. Yaméogo JB; Géze A; Choisnard L; Putaux JL; Semdé R; Wouessidjewe D Curr Top Med Chem; 2014; 14(4):526-41. PubMed ID: 24354667 [TBL] [Abstract][Full Text] [Related]
58. Fabrication of solid nanoparticles for drug delivery. Arayne MS; Sultana N; Noor-Us-Sabah Pak J Pharm Sci; 2007 Jul; 20(3):251-9. PubMed ID: 17545113 [TBL] [Abstract][Full Text] [Related]
59. In vitro cellular localization and efficient accumulation of fluorescently tagged biomaterials from monodispersed chitosan nanoparticles for elucidation of controlled release pathways for drug delivery systems. Hassan UA; Hussein MZ; Alitheen NB; Yahya Ariff SA; Masarudin MJ Int J Nanomedicine; 2018; 13():5075-5095. PubMed ID: 30233174 [TBL] [Abstract][Full Text] [Related]
60. Pharmaceutical approaches to colon targeted drug delivery systems. Chourasia MK; Jain SK J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]